What is Alnylam Pharmaceuticals's net change in cash?

Alnylam Pharmaceuticals (ALNY) reported net change in cash of $53.61M in Q1 2026.

How has Alnylam Pharmaceuticals's net change in cash changed year-over-year?

Alnylam Pharmaceuticals's net change in cash increased by 0.0% year-over-year, from $53.6M to $53.61M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Alnylam Pharmaceuticals ALNY Net Change in Cash

Net Change in Cash at other companies

Ionis PharmaceuticalsIONS

-$198.88M-999%

Arrowhead ResearchARWR

-$14.12M-111%

PTC TherapeuticsPTCT

-$147.9M-121%

Assembly BiosciencesASMB

-$27.33M-83.0%

Arbutus Biopharma CorporationABUS

$5.7M+664%

Wave Life SciencesWVE

-$176.58M-411%

Other financials

Income statement

See full

Revenue$1.3B+66.9%

Gross profit$992.7M+57.2%

Operating income$231.4M+1,529%

Net income$164.5M+348%

EPS (diluted)$1.21+337%

Balance sheet

See full

Cash & equivalents$1.7B+53.2%

Total debt$256.4M-5.2%

Total equity$1.4B+440%

Total assets$5.6B+21.7%

Cash flow

See full

Operating cash flow$326.7M+113%

CapEx$34.7M+143%

Free cash flow$292.0M+109%

Valuation

See full

Market cap$38.51B-10.7%

Enterprise value$37.05B-12.3%

P/E52.5×—

P/S8×-9.5×

Profitability

See full

Gross margin79.8%-4.1pp

Operating margin20.8%+16.5pp

Net margin15.3%+10.7pp

FCF margin16.5%+14.8pp

Returns & leverage

See full

Return on equity91.4%—

Debt / equity0.2×-0.9×

Current ratio3.1×+0.3×

Where this comes from

Reported directly by Alnylam Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Alnylam Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alnylam Pharmaceuticals's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Alnylam Pharmaceuticals's net change in cash?: Alnylam Pharmaceuticals (ALNY) reported net change in cash of $53.61M in Q1 2026.
How has Alnylam Pharmaceuticals's net change in cash changed year-over-year?: Alnylam Pharmaceuticals's net change in cash increased by 0.0% year-over-year, from $53.6M to $53.61M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.